Management of early rectal cancer; current surgical options and future direction

Vijay Chavda1, Oliver Siaw1, Sanjay Chaudhri1

  • 1Department of General Surgery, Leicester General Hospital, Leicester LE5 4PW, United Kingdom.

Insights

Early rectal cancer detection is increasing due to screening. Minimally invasive local excision is currently limited, but future multimodal treatments may expand its role in rectal cancer management.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Clinical Research

Background:

  • Rectal cancer is a leading cause of cancer mortality in the UK.
  • National screening programs increase early-stage rectal cancer diagnoses.
  • Advancements in local excision techniques include transanal endoscopic microsurgery, transanal endoscopic operation, and transanal minimally invasive surgery.

Purpose of the Study:

  • To review current management strategies for early rectal cancer.
  • To outline available surgical options for local excision.
  • To discuss the future multimodal treatment directions for early rectal cancer.

Main Methods:

  • Literature review of current management practices.
  • Analysis of surgical techniques for local excision.
  • Evaluation of ongoing and recent clinical trials (e.g., GRECCAR II, TESAR, STAR-TREC).

Main Results:

  • Minimally invasive local excision is currently restricted to pre-invasive and low-risk T1N0M0 rectal cancer due to local recurrence risks.
  • The roles of chemotherapy and radiotherapy in early rectal cancer remain under investigation.
  • Emerging research suggests potential for expanded local excision roles when combined with other therapies.

Conclusions:

  • Current management of early rectal cancer involves local excision for select cases.
  • Future treatment paradigms may involve multimodal approaches combining surgery with chemotherapy and/or radiotherapy.
  • Ongoing research is crucial for defining the optimal role of local excision in early rectal cancer management.